Sanofi, Regeneron start Phase 3 trial of dupilumab in eczema
October 20, 2014 at 01:18 AM EDT
PARIS, Oct 20 (Reuters) - French drugmaker Sanofi and its U.S. partner Regeneron said on Monday they had started a Phase III clinical study of their experimental drug dupilumab in patients with atopic dermatitis.
